Brainstorm Cell Therapeutics Inc. (BCLI)
R&D Expenses
-$782.00K
TTM · Period ending: · USD
BCLI R&D Expenses
Latest reported-$782.00Kperiod ending
Latest reported-$782.00Kperiod ending
BCLI TTM R&D Expenses ($0.00 → -$782.00K)
TTM R&D Expenses
High-resolution chart · PNG
BCLI r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| -782,000 | |
| -579,000 | |
| 0 | |
| 5,046,000 | |
| 5,192,000 | |
| 4,994,000 | |
| 4,587,000 | |
| 4,562,000 | |
| 6,847,000 | |
| 8,719,000 | |
| 10,746,000 | |
| 11,499,000 | |
| 11,945,000 | |
| 14,264,000 | |
| 13,956,000 | |
| 15,182,000 | |
| 15,024,000 | |
| 13,510,000 | |
| 15,235,000 | |
| 20,378,000 | |
| 18,627,000 | |
| 20,722,000 | |
| 22,329,000 | |
| 19,695,000 | |
| 21,836,000 | |
| 19,696,000 | |
| 17,204,000 | |
| 14,878,000 | |
| 12,845,000 | |
| 10,772,000 | |
| 8,293,000 | |
| 2,866,000 | |
| 2,059,000 | |
| 1,013,000 | |
| 977,000 | |
| 2,867,000 | |
| 2,489,000 | |
| 2,205,000 | |
| 2,250,000 | |
| 2,753,000 | |
| 3,466,000 | |
| 4,690,000 | |
| 4,949,000 | |
| 5,766,000 | |
| 5,835,000 | |
| 5,337,000 | |
| 4,772,000 | |
| 3,978,000 | |
| 3,210,000 | |
| 3,075,000 | |
| 2,917,000 | |
| 2,352,000 | |
| 2,280,000 | |
| 1,923,000 | |
| 1,770,000 | |
| 2,143,000 | |
| 1,587,000 | |
| 1,788,000 | |
| 1,689,000 | |
| 1,119,000 | |
| 1,314,000 | |
| 1,076,000 | |
| 1,045,000 | |
| 365,000 | |
| 269,000 | |
| 131,000 | |
| 181,000 | |
| 1,248,000 | |
| 1,265,000 | |
| 1,338,000 | |
| 1,639,000 | |
| 1,768,000 | |
| 1,802,000 | |
| 1,925,000 | |
| 1,925,407 | |
| 2,130,783 | |
| 2,073,783 | |
| 1,867,908 | |
| 1,269,473 | |
| 801,229 | |
| 856,580 | |
| 846,947 | |
| 906,420 | |
| 16,865,336 | |
| 16,540,985 | |
| 16,350,493 | |
| 16,299,048 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |